Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

ACP 2024 Insights: Cancer of Unknown Primary

Insights from 2024 ACP Annual Meeting

S. Brondfield

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

Palliative Medicine in Cancer Patients

Houston Methodist

E. De Leon

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Sexual Health and Wellbeing in Women’s Cancer Survivors

Stanford Medicine

M. Dolezal

Chemotherapy-Induced Hair Loss: Insights and Effective Strategies

Masonic Cancer Center, University of Minnesota

M. Hordinsky

The Importance of Exercise for Cancer Survivorship

Oncology Data Advisor

N. Seetharamu

Understanding Your Cancer Risk and Options for Cancer Prevention

Yale Cancer Center

V. Giri, T. Shroff

NGS in Glioblastoma: Clinically Relevant Genomics

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

J. Morrissette

ctDNA and MRD: Who, What, and Then What?

Total Health

A. Parikh